The FDA has submitted its Enforcement Discretion Policy for CBD to the White House, which means we are finally going to get our very first regulations for CBD Products since hemp was federally legalized in December 2018
Canopy Growth is the largest cannabis company in the world and has worked most closely with the FDA on CBD, so they would be in the best position to know how the FDA feels about the differing CBD formulations:
The Senate may have a counter proposal that would be very watered down when it comes to MJ Banking, but would fully open up Hemp Banking — we haven’t seen this proposal yet, but it may be introduced into the economic stimulus bill negotiations next week once the House and Senate reach agreement on the bare bones (unemployment, stimulus checks, PPP) aspects of the bill
Pure CBD (CBD Isolate) Legalization would be a logical move to be included in the economic stimulus bill, especially if all 3 formulations fall under the FDA’s Enforcement Discretion Policy
Jonathan Miller has been very enthusiastically touting the legislative prospects of Pure CBD Legalization, as recently as July 23rd (last link below), and he is the party closest to Mitch
Miller is the only public figure who predicted the introduction of HR 5587, which would legalize Pure CBD in Dietary Supplements and Foods/Beverages, so he has a track record of being very close to the situation in Congress:
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.